Medication (how supplied) | United States trade name (generic availability) | Duration of action | Initial dose* | Dose advancement* | Maximum dose (per day) |
Methylphenidate | |||||
|
|
|
|
|
|
Dexmethylphenidate¶ | |||||
|
|
|
|
|
|
Amphetamine | |||||
|
|
| 3 to 5 years | ||
|
|
| |||
≥6 years | |||||
|
|
| |||
Amphetamine | |||||
|
|
| ≥6 years | ||
|
|
| |||
Dextroamphetamine | |||||
|
|
| 3 to 5 years | ||
|
|
| |||
≥6 years | |||||
|
|
| |||
Dextroamphetamine-amphetamine | |||||
|
|
| 3 to 5 years |
| |
|
| ||||
≥6 years | |||||
|
|
* Doses of immediate-release preparations are given in the morning on rising and at lunch time 4 to 6 hours later. Three times per day dosing is an option for children needing control of symptoms in the late afternoon or early evening.
¶ Dexmethylphenidate may not be an appropriate choice for children aged <6 years, due to its relatively higher potency and lack of commercially available chewable tablets or flavored oral solution.
Δ Doses above 40 mg per day total are rarely needed and warrant close monitoring for adverse effects.Prepared with additional data from the US Food and Drug Administration approved product information, available at www.accessdata.fda.gov/scripts/cder/daf/index.cfm (accessed on October 4, 2022).
Do you want to add Medilib to your home screen?